HQL

abrdn Life Sciences Investors
HQL

Overview Fund Activity

74 hedge funds and large institutions have $149M invested in abrdn Life Sciences Investors in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 10 closing their positions.

Holders
74
Holders Change
+1
Holders Change %
+1.37%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
19
Reduced
28
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
1
Penserra Capital Management
California
$11.7M
2
SIA
2
Sit Investment Associates
Minnesota
$6.29M
3
KIM
3
Karpus Investment Management
New York
$7.07M
4
WAM
4
WNY Asset Management
New York
$319K
5
Cetera Investment Advisers
5
Cetera Investment Advisers
Illinois
$2.59M

Top Sellers

1
RL
1
RPO LLC
Connecticut
$0
2
BFM
2
Boothbay Fund Management
New York
$0
3
AW
3
Atlas Wealth
Ohio
$0
4
AA
4
AQR Arbitrage
Connecticut
$3.97M
5
1CP
5
1607 Capital Partners
Virginia
$5.27M
Name Holding Trade Value Shares
Change 		Shares
Change %
RL
76
RPO LLC
Connecticut
– -$3.67M -259,275 Closed
BFM
77
Boothbay Fund Management
New York
– -$1.65M -116,674 Closed
AW
78
Atlas Wealth
Ohio
– -$1.19M -83,322 Closed
LCM
79
Landscape Capital Management
New Jersey
– -$786K -55,453 Closed
GC
80
Guggenheim Capital
Illinois
– -$390K -27,505 Closed
CA
81
Cornerstone Advisors
North Carolina
– -$317K -22,339 Closed
ACA
82
Atlas Capital Advisors
Wyoming
– -$1.96K -138 Closed
RCM
83
Raleigh Capital Management
North Carolina
– -$1.47K -104 Closed
CIBC Private Wealth Group
84
CIBC Private Wealth Group
Georgia
– -$416 -29 Closed
Fidelity Investments
85
Fidelity Investments
Massachusetts
– -$28 -2 Closed
1 2 3
4